ISFR:LSE:LSE-iShares MSCI France UCITS (GBX)

ETF | Others |

Last Closing

USD 4941

Change

-19.50 (-0.39)%

Market Cap

USD 0.16B

Volume

517.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-4.00 (-1.86%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-7.31 (-5.47%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.31%)

USD 588.35B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.10 (+0.54%)

USD 588.35B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.70 (+0.99%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.16 (+0.54%)

USD 260.39B
0QZO:LSE 0QZO

-0.30 (-0.27%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-2.89 (-1.76%)

USD 202.26B
0R24:LSE Intel Corp.

-1.31 (-5.34%)

USD 196.14B

ETFs Containing ISFR:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.05% 86% B+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.05% 86% B+ 79% B-
Trailing 12 Months  
Capital Gain 1.77% 26% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.77% 20% F 36% F
Trailing 5 Years  
Capital Gain 56.02% 65% D 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 56.02% 63% D 72% C
Average Annual (5 Year Horizon)  
Capital Gain 12.28% 68% D+ 71% C-
Dividend Return 12.28% 67% D+ 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.56% 57% F 74% C
Risk Adjusted Return 97.80% 87% B+ 92% A
Market Capitalization 0.16B 56% F 32% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike